2016-03-05T00:00:00.000-05:00
renal diseases,-0.710736
Keryx Biopharmaceuticals Daily,0.407197
price target,0.340147
quarterly earnings results,-0.250176
share,0.211586
stock,-0.0381633
related companies,0.577892
InvestorPlace Broker Center,0.555736
biopharmaceutical company,0.445137
high fees,-0.735674
Keryx Biopharmaceuticals,-0.0554493
earnings,-0.262762
Zacks Investment Research,0.349031
personal trading style,0.598412
average rating,-0.360175
FBR,0.487001
research note,0.340147
research offerings,0.40995
chronic kidney disease,-0.549539
consensus estimate,-0.207575
average target price,-0.373157
concise daily summary,0.509958
serum phosphorus levels,-0.549539
Co. analyst C.,0.487001
stock broker,0.245696
rating,-0.00773948
